Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-step oral penicillin challenge for reported low-risk penicillin allergy in children
ACTRN12625000359437Phase 3Not yet recruiting
- Sponsor
- WA Health
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Benzathine penicillin in penicillin allergy, sponsored by WA Health. Primary endpoints: Prevalence of immediate reactions to one-step penicillin challenge and Safety and severity of immediate reactions. Planned start May 2025; status: not yet recruiting.
02
Drugs
Benzathine penicillin
03
Conditions
penicillin allergy
Beyond the preview
Go deeper on ACTRN12625000359437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000359437.